BioCorRx, Inc. v. VDM BioChemicals, Inc.
Opinion
Trial Court Opinion
I. BACKGROUND
The following facts are alleged in BioCor’s complaint. Compl., Ex. A, Dkt. No. 1- 1. BioCor is a healthcare solutions company focused on providing novel treatment approaches for alcohol addiction, opioid addiction, and other addiction disorders. Id. ¶ 1. BioCor and Defendants entered into non-disclosure and co-development agreements for the purpose of developing and commercializing a chemical compound called “VDM- 001”. Id. ¶¶ 5, 9, 19. Pursuant to these agreements, BioCor agreed to provide the capital and expertise to conduct studies required to validate, develop, and commercialize VDM- 001 in exchange for an ownership interest in VDM-001. Id. ¶¶ 9, 25. BioCor funded several studies, engaged consultants, and provided other resources for the development of
CUENNTITREADL S DTIASTTERSIC DTI SOTFR CICATL ICFOOURRNTIA
CIVIL MINUTES - GENERAL
Case No. SACV 21-938 JVS (KESx) Date July 21, 2021 Title BioCorRX, Inc. v. VDM Biochemicals, Inc. et al.
provided Defendants with critical direction on what studies to conduct, shared its know- how and trade secrets regarding the development of drug treatments, and shared its ideas regarding novel…